Reducing CVD Risk in the Metabolic Syndrome and Type 2 Diabetes: Novel Approaches to Studies of Lipoprotein Metabolism

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/572587

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The incidence of obesity and diabetes is increasing in Australia. With these two conditions comes an increase in cardiovascular disease risk. Elevated blood lipids are an important component of this increased. Weight loss and cholesterol lowering drugs are first line therapies for obesity and diabetes, respectively. Niacin is effective at lowering lipids and raising HDL cholesterol, but the mechanisms responsible for these changes have not been determined.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2011

Funding Scheme: NHMRC Project Grants

Funding Amount: $548,669.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nutritional science

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Cardiovascular disease | Hyperlipidemia | Insulin resistance and obesity | Lipoprotein metabolism | Metabolic tracer studies | Systems biology | Type 2 diabetes

Related Links